Amerise Biosciences Limited (BOM:531681)

Amerise Biosciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	47	39	60	44	46	90
Market Cap Growth	-11.25%	-35.16%	37.88%	-5.71%	-48.53%	-17.58%
Enterprise Value	41	39	60	45	46	90
Last Close Price	0.71	0.59	0.91	0.66	0.70	1.36
PE Ratio	270.37	242.12	1054.79	-	-	16.36
PS Ratio	-	-	31.98	121.46	525.55	0.94
PB Ratio	0.87	0.72	1.12	0.81	0.84	1.59
P/TBV Ratio	0.87	0.72	1.12	0.81	0.84	1.59
P/OCF Ratio	-	-	1.96	-	-	146.34
EV/Sales Ratio	-	-	31.90	124.09	524.95	0.94
EV/EBIT Ratio	198.98	188.08	768.77	-	-	16.32
Debt / Equity Ratio	-	-	-	-	0.02	0.02
Net Debt / Equity Ratio	-0.11	-0.11	0.00	0.00	0.01	0.01
Asset Turnover	-	-	0.03	0.01	0.00	1.09
Quick Ratio	0.29	0.29	0.01	1.36	0.37	0.99
Current Ratio	0.30	0.30	0.01	1.48	0.37	0.99
Return on Equity (ROE)	0.30%	0.30%	0.11%	-2.68%	-2.13%	10.24%
Return on Assets (ROA)	0.16%	0.16%	0.07%	-1.65%	-1.18%	3.90%
Return on Invested Capital (ROIC)	0.32%	0.32%	0.11%	-2.66%	-2.93%	10.12%
Return on Capital Employed (ROCE)	0.40%	0.40%	0.10%	-2.70%	-3.00%	9.60%
Earnings Yield	0.34%	0.41%	0.10%	-3.35%	-2.57%	6.11%
Buyback Yield / Dilution	7.22%	7.22%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.